A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples